Prevention of postmenopausal bone loss and endometrial responses during a two year prospective study with transdermal 17 beta-estradiol and oral medroxyprogesterone acetate.
Academic Article
Publication Date:
1991
Short description:
Prevention of postmenopausal bone loss and endometrial responses during a two year prospective study with transdermal 17 beta-estradiol and oral medroxyprogesterone acetate / P., Fioretti; M., Gambacciani; A., Spinetti; Cagnacci, Angelo; A. M., Paoletti; R., Felipetto; G. B., Melis. - In: ANNALS OF THE NEW YORK ACADEMY OF SCIENCES. - ISSN 0077-8923. - STAMPA. - 622:(1991), pp. 302-306. [10.1111/j.1749-6632.1991.tb37875.x]
abstract:
..
Iris type:
Articolo su rivista
Keywords:
Administration; Cutaneous, Administration; Oral, Antineoplastic Agents; administration /&/ dosage/pharmacology/therapeutic use, Endometrium; drug effects/physiology, Estradiol; administration /&/ dosage/pharmacology/therapeutic use, Female, Humans, Medroxyprogesterone Acetate, Medroxyprogesterone; administration /&/ dosage/analogs /&/ derivatives/pharmacology/therapeutic use, Middle Aged, Osteoporosis; drug therapy/prevention /&/ control
List of contributors:
P., Fioretti; M., Gambacciani; A., Spinetti; Cagnacci, Angelo; A. M., Paoletti; R., Felipetto; G. B., Melis
Published in: